Inactive Total Small Business Set-Aside (FAR 19.5)

RFQ 1230535 FY20 Annual Send Explorer Warehouse and Technical Support This is a combined synopsis/solicitation for commercial items prepared in accordance with the format in Subpart 12.6, as supplemen... RFQ 1230535 FY20 Annual Send Explorer Warehouse and Technical Support This is a combined synopsis/solicitation for commercial items prepared in accordance with the format in Subpart 12.6, as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; proposals are being requested and a written solicitation will not be issued. Solicitation Number: 1230535. This is a Request for Quotes. the solicitation document and incorporated provisions and clauses are those in effect through Federal Acquisition Circular 2019-04_2. Small Business Set Aside for NAICS 541519, size standard $27,500,000.00. Line Items as follows (note: All fixed price). Annual Send Explorer Warehouse License, or equal to solution 08/01/2020-07/31/2021 Annual technical support 08/01/2020-07/31/2021 The requirement is for software maintenance and support for the software SEND Explorer Warehouse The FDA owns the perpetual license for this software. Delivery address is: Office of Computational Science ATTN: Xiaojun Jie/Karen Zeiter 10903 New Hampshire Avenue White Oak Building 21, Room 1505 Silver Spring, MD 20993 Dates and duration of maintenance periods are listed in paragraph v. The provision at 52.212-1, Instructions to Offerors -- Commercial, applies to this acquisition, with the following addenda: This is a brand name or equal only solicitation. The provision at 52.212-2, Evaluation -- Commercial Items applies to this acquisition. Factors considered are: Price Only. Offerors verifies that by summiting an offer their annual representations and certifications are complete and accessible in SAM, per FAR 52.212-3 Offeror Representations and Certifications -- Commercial Items (Oct 2018). Additional contract requirements are listed in the addenda. DPAS and ratings are not applicable. Offers due 7/20/2020 Contact is Steven Gagnon Steven.gagnon@fda.hhs.gov